+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Human Milk Oligosaccharides Market by Product (2'-Fucosyllactose(2'FL), 3'-Fucosyllactose (3'FL), 3'-Sialyllactose (3'SL)), Type (Acidic, Neutral), Application - Forecast 2024-2030- Product Image
Global Human Milk Oligosaccharides Market by Product (2'-Fucosyllactose(2'FL), 3'-Fucosyllactose (3'FL), 3'-Sialyllactose (3'SL)), Type (Acidic, Neutral), Application - Forecast 2024-2030- Product Image
Sale

Global Human Milk Oligosaccharides Market by Product (2'-Fucosyllactose(2'FL), 3'-Fucosyllactose (3'FL), 3'-Sialyllactose (3'SL)), Type (Acidic, Neutral), Application - Forecast 2024-2030

  • PDF Icon

    Report

  • 195 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 4896841
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Human Milk Oligosaccharides Market size was estimated at USD 297.90 million in 2023, USD 323.44 million in 2024, and is expected to grow at a CAGR of 9.72% to reach USD 570.55 million by 2030.

Human milk oligosaccharides (HMOs) are a mixed group of complex carbohydrates naturally present in human breast milk. They represent human milk's third enormous solid component after lactose and fat. As non-digestible food ingredients, HMOs serve multiple functions that contribute to the advantageous effects of human milk on infant health and development. HMOs play a critical role in developing an infant's gut microbiota, acting as prebiotics by selectively encouraging the development of beneficial bacteria, including Bifidobacteria and Lactobacillus. This helps establish a healthy intestinal environment that supports nutrient absorption and protects against pathogenic bacteria.

Additionally, their utilization extends into functional foods and dietary supplements owing to their prebiotic and anti-pathogenic properties. HMOs are also studied for therapeutic potentials in gastroenterology, immunology, and oncology. The market is driven by the scientific consensus on the advantages of breastfeeding and the rising awareness of the benefits of HMOs. Technological advancements in the synthesis and extraction of HMOs contribute to market expansion. A growing infant formula industry, rising health concerns, and increasing purchasing power contributed significantly to the HMO market's growth. However, the growth of HMOs is hampered by high research and development costs associated with HMO production, regulatory challenges, the requirement for extensive safety evaluations before approvals, and the complexity of synthesizing HMOs that are identical to the ones found in human milk. On the other hand, the latest potential opportunities in the HMO market include the development of new and more cost-effective extraction and synthesis methods for a broader range of HMO compounds. Another area of opportunity lies in expanding the applications beyond dietary supplements and infant nutrition, particularly in gut health, immunity boosters, and therapeutic agents. Collaboration with healthcare institutions for clinical trials and academic institutions for research can create opportunities for market players.

Regional Insights

The United States holds a significant share of the global HMOs market, driven by robust R&D initiatives and consumer awareness regarding infant nutrition. The region has witnessed growing demand for HMO-enhanced infant formula, attributed to the increasing need for nutritionally rich alternatives to breast milk. In Canada, consumer interest in advanced nutritional compositions for infants, including HMO-supplemented formulas, is growing. However, the market is just budding, and consumer purchasing behavior tends to lean toward trusted brands and scientifically backed products. The market for HMOs in South America is in a developing stage. Countries such as Brazil and Argentina are increasingly demanding advanced infant nutrition products.

The European Union presents a mature market for HMOs, with a strong focus on infant nutrition and well-being. Countries such as Denmark and Germany are leading in terms of HMO research and production. EU regulations are stringent on product safety and quality, requiring companies to undergo rigorous evaluations. This has led to a customer base that is well-informed and discerning. While the market for HMOs is less pronounced in the Middle East and Africa, there is a noticeable increase in demand tied to rising incomes and an emerging middle class. Interest in advanced nutritional formulas for infants is growing, although the awareness and understanding of HMOs benefits are still developing. The APAC region is witnessing a rapid increase in demand for HMOs, particularly in countries such as India, China, and Japan. China has quickly become a primary market for HMOs in Asia, with national policies endorsing breastfeeding and higher-quality infant formula. Japan is known for its high standards in food safety and quality, which extends to the HMO market. Japanese consumers are health-conscious and show readiness to adopt scientifically-supported products, contributing to a steady demand for HMO-supplemented formulas. India is seen as an emerging market with vast potential for HMOs due to its large population and increasing focus on nutritional security. The awareness of the importance of early childhood nutrition is on the rise, and companies aim to capture this market by scaling up investment and promoting informed consumer behavior.

Market Trends by Segment

  • Product: Increasing preference for 2’-Fucosyllactose(2’FL) due to its abundance in human milk and proven health benefits
  • Application: Growing application of HMOs for replicating the complex health-sustaining properties of breast milk for infants

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Nestlé launches its first product with HMOs in China, reinforcing its global leadership in nutrition science

Nestlé S.A. has entered the early life nutrition market in mainland China, releasing its Wyeth illuma line of growing-up milk fortified with Human Milk Oligosaccharides (HMOs) following the National Health Commission's authorization. This product includes vital HMOs like 2'Fucosyllactose (2'FL) and Lacto-N-(neo)tetraose (LNnT), integral to boosting gut health, immunity, and cognitive development in young children.

Firmenich Completes Merger Of Equals With Dsm

Koninklijke DSM N.V. and Firmenich International SA have concluded their merger, creating DSM-Firmenich AG, a prominent player in nutrition, health, and beauty innovation. The completion follows the fulfillment of all standard regulatory conditions, including the execution of a share exchange offer and the integration of Firmenich shares into the merged entity.

Novozymes Agrees to Buy Chr. Hansen in USD 12.3 Billion Deal

Novozymes A/S has agreed to acquire Chr. Hansen Holding A/S for approximately USD 12.3 billion. The proposed stock-for-stock transaction is likely to enhance Novozymes' portfolio with Chr. Hansen's expertise in natural food ingredients and probiotics.

Key Company Profiles

The report delves into recent significant developments in the Human Milk Oligosaccharides Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Advanced Protein Technologies Corp., Agilent Technologies, Inc., BASF SE, Biosynth AG, Chr. Hansen Holding A/S, Conagen, Inc., Dextra Laboratories Ltd, DuPont de Nemours, Inc., Elicityl SA, Glycosyn LLC, Gnubiotics Sciences SA, Inbiose NV, Kirin Holdings Company, Limited, Koninklijke DSM N.V., Laïta Nutrition, Lonza Group AG, Nestlé S.A., Roquette Frères, Royal FrieslandCampina N.V., Tate & Lyle PLC, TurtleTree, and ZuChem, Inc.

This research report offers invaluable insights into various crucial aspects of the Human Milk Oligosaccharides Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase HMO Application in Infant Formula and Functional Food owing to the Nutritional Value
5.1.1.2. Rising Awareness Regarding the Concerns Related to Child Malnourishment and Mortality all Over the Globe
5.1.1.3. Increasing Demand for HMOs Supplements in Adults
5.1.2. Restraints
5.1.2.1. High Cost associated with the R&D and Large Production
5.1.3. Opportunities
5.1.3.1. Advancement in the Product Line of HMOs
5.1.3.2. Rising Demand for Nutritional Supplements from China and India
5.1.4. Challenges
5.1.4.1. Regulatory Framework Specific to Countries and Regions
5.2. Market Segmentation Analysis
5.2.1. Product: Increasing preference for 2’-Fucosyllactose(2’FL) due to its abundance in human milk and proven health benefits
5.2.2. Application: Growing application of HMOs for replicating the complex health-sustaining properties of breast milk for infants
5.3. Market Trend Analysis
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter’s Five Forces Analysis
5.6.1. Threat of New Entrants
5.6.2. Threat of Substitutes
5.6.3. Bargaining Power of Customers
5.6.4. Bargaining Power of Suppliers
5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis
5.9. Client Customization
6. Human Milk Oligosaccharides Market, by Product
6.1. Introduction
6.2. 2’-Fucosyllactose(2’FL)
6.3. 3’-Fucosyllactose (3’FL)
6.4. 3’-Sialyllactose (3’SL)
6.5. 6’-Sialyllactose (6’SL)
6.6. Lacto-n-neotetraose (LNnT)
6.7. Lacto-n-tetraose (LNT)
7. Human Milk Oligosaccharides Market, by Type
7.1. Introduction
7.2. Acidic
7.3. Neutral
8. Human Milk Oligosaccharides Market, by Application
8.1. Introduction
8.2. Functional Food & Supplements
8.3. Infant Formulas
8.4. Laboratory Research
9. Americas Human Milk Oligosaccharides Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Human Milk Oligosaccharides Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Human Milk Oligosaccharides Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Nestlé launches its first product with HMOs in China, reinforcing its global leadership in nutrition science
12.3.2. Firmenich Completes Merger Of Equals With Dsm
12.3.3. Novozymes Agrees to Buy Chr. Hansen in USD 12.3 Billion Deal
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. HUMAN MILK OLIGOSACCHARIDES MARKET RESEARCH PROCESS
FIGURE 2. HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. HUMAN MILK OLIGOSACCHARIDES MARKET DYNAMICS
FIGURE 7. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 10. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. HUMAN MILK OLIGOSACCHARIDES MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. HUMAN MILK OLIGOSACCHARIDES MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. HUMAN MILK OLIGOSACCHARIDES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY 2’-FUCOSYLLACTOSE(2’FL), BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY 2’-FUCOSYLLACTOSE(2’FL), BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY 3’-FUCOSYLLACTOSE (3’FL), BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY 3’-FUCOSYLLACTOSE (3’FL), BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY 3’-SIALYLLACTOSE (3’SL), BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY 3’-SIALYLLACTOSE (3’SL), BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY 6’-SIALYLLACTOSE (6’SL), BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY 6’-SIALYLLACTOSE (6’SL), BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY LACTO-N-NEOTETRAOSE (LNNT), BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY LACTO-N-NEOTETRAOSE (LNNT), BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY LACTO-N-TETRAOSE (LNT), BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY LACTO-N-TETRAOSE (LNT), BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY ACIDIC, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY ACIDIC, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY NEUTRAL, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY NEUTRAL, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY FUNCTIONAL FOOD & SUPPLEMENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY FUNCTIONAL FOOD & SUPPLEMENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY INFANT FORMULAS, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY INFANT FORMULAS, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY LABORATORY RESEARCH, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY LABORATORY RESEARCH, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. AMERICAS HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 36. AMERICAS HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 37. AMERICAS HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 38. AMERICAS HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 39. AMERICAS HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 40. AMERICAS HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 41. AMERICAS HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 42. AMERICAS HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 43. ARGENTINA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 44. ARGENTINA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 45. ARGENTINA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 46. ARGENTINA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 47. ARGENTINA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 48. ARGENTINA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 49. BRAZIL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 50. BRAZIL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 51. BRAZIL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 52. BRAZIL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 53. BRAZIL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 54. BRAZIL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 55. CANADA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 56. CANADA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 57. CANADA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 58. CANADA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 59. CANADA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 60. CANADA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 61. MEXICO HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 62. MEXICO HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 63. MEXICO HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 64. MEXICO HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 65. MEXICO HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 66. MEXICO HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 67. UNITED STATES HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 68. UNITED STATES HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 69. UNITED STATES HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 70. UNITED STATES HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 71. UNITED STATES HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 72. UNITED STATES HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 73. UNITED STATES HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 74. UNITED STATES HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 76. ASIA-PACIFIC HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 78. ASIA-PACIFIC HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 80. ASIA-PACIFIC HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 82. ASIA-PACIFIC HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 83. AUSTRALIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 84. AUSTRALIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 85. AUSTRALIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 86. AUSTRALIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 87. AUSTRALIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 88. AUSTRALIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 89. CHINA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 90. CHINA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 91. CHINA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 92. CHINA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 93. CHINA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 94. CHINA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 95. INDIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 96. INDIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 97. INDIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 98. INDIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 99. INDIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 100. INDIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 101. INDONESIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 102. INDONESIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 103. INDONESIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 104. INDONESIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 105. INDONESIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 106. INDONESIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 107. JAPAN HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 108. JAPAN HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 109. JAPAN HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 110. JAPAN HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 111. JAPAN HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 112. JAPAN HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 113. MALAYSIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 114. MALAYSIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 115. MALAYSIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 116. MALAYSIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 117. MALAYSIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 118. MALAYSIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 119. PHILIPPINES HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 120. PHILIPPINES HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 121. PHILIPPINES HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 122. PHILIPPINES HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 123. PHILIPPINES HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 124. PHILIPPINES HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 125. SINGAPORE HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 126. SINGAPORE HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 127. SINGAPORE HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 128. SINGAPORE HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 129. SINGAPORE HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 130. SINGAPORE HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 131. SOUTH KOREA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 132. SOUTH KOREA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 133. SOUTH KOREA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 134. SOUTH KOREA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 135. SOUTH KOREA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 136. SOUTH KOREA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 137. TAIWAN HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 138. TAIWAN HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 139. TAIWAN HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 140. TAIWAN HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 141. TAIWAN HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 142. TAIWAN HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 143. THAILAND HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 144. THAILAND HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 145. THAILAND HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 146. THAILAND HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 147. THAILAND HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 148. THAILAND HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 149. VIETNAM HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 150. VIETNAM HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 151. VIETNAM HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 152. VIETNAM HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 153. VIETNAM HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 154. VIETNAM HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 163. DENMARK HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 164. DENMARK HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 165. DENMARK HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 166. DENMARK HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 167. DENMARK HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 168. DENMARK HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 169. EGYPT HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 170. EGYPT HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 171. EGYPT HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 172. EGYPT HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 173. EGYPT HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 174. EGYPT HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 175. FINLAND HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 176. FINLAND HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 177. FINLAND HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 178. FINLAND HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 179. FINLAND HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 180. FINLAND HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 181. FRANCE HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 182. FRANCE HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 183. FRANCE HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 184. FRANCE HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 185. FRANCE HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 186. FRANCE HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 187. GERMANY HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 188. GERMANY HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 189. GERMANY HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 190. GERMANY HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 191. GERMANY HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 192. GERMANY HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 193. ISRAEL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 194. ISRAEL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 195. ISRAEL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 196. ISRAEL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 197. ISRAEL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 198. ISRAEL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 199. ITALY HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 200. ITALY HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 201. ITALY HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 202. ITALY HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 203. ITALY HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 204. ITALY HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 205. NETHERLANDS HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 206. NETHERLANDS HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 207. NETHERLANDS HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 208. NETHERLANDS HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 209. NETHERLANDS HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 210. NETHERLANDS HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 211. NIGERIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 212. NIGERIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 213. NIGERIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 214. NIGERIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 215. NIGERIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 216. NIGERIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 217. NORWAY HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 218. NORWAY HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 219. NORWAY HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 220. NORWAY HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 221. NORWAY HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 222. NORWAY HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 223. POLAND HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 224. POLAND HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 225. POLAND HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 226. POLAND HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 227. POLAND HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 228. POLAND HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 229. QATAR HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 230. QATAR HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 231. QATAR HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 232. QATAR HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 233. QATAR HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 234. QATAR HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 235. RUSSIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 236. RUSSIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 237. RUSSIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 238. RUSSIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 239. RUSSIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 240. RUSSIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 242. SAUDI ARABIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 244. SAUDI ARABIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 246. SAUDI ARABIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 248. SOUTH AFRICA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 250. SOUTH AFRICA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 252. SOUTH AFRICA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 253. SPAIN HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 254. SPAIN HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 255. SPAIN HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 256. SPAIN HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 257. SPAIN HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 258. SPAIN HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 259. SWEDEN HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 260. SWEDEN HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 261. SWEDEN HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 262. SWEDEN HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 263. SWEDEN HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 264. SWEDEN HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 265. SWITZERLAND HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 266. SWITZERLAND HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 267. SWITZERLAND HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 268. SWITZERLAND HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 269. SWITZERLAND HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 270. SWITZERLAND HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 271. TURKEY HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 272. TURKEY HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 273. TURKEY HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 274. TURKEY HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 275. TURKEY HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 276. TURKEY HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 284. UNITED KINGDOM HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 286. UNITED KINGDOM HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 288. UNITED KINGDOM HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 289. HUMAN MILK OLIGOSACCHARIDES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 290. HUMAN MILK OLIGOSACCHARIDES MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

  • Abbott Laboratories
  • Advanced Protein Technologies Corp.
  • Agilent Technologies, Inc.
  • BASF SE
  • Biosynth AG
  • Chr. Hansen Holding A/S
  • Conagen, Inc.
  • Dextra Laboratories Ltd
  • DuPont de Nemours, Inc.
  • Elicityl SA
  • Glycosyn LLC
  • Gnubiotics Sciences SA
  • Inbiose NV
  • Kirin Holdings Company, Limited
  • Koninklijke DSM N.V.
  • Laïta Nutrition
  • Lonza Group AG
  • Nestlé S.A.
  • Roquette Frères
  • Royal FrieslandCampina N.V.
  • Tate & Lyle PLC
  • TurtleTree
  • ZuChem, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages195
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 323.44 Million
Forecasted Market Value ( USD ) by 2030 $ 570.55 Million
Compound Annual Growth Rate9.7%
Regions CoveredGlobal
No. of Companies Mentioned23

Related Topics

Related Reports

Global Human Milk Oligosaccharides - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Global Human Milk Oligosaccharides - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 130 Pages
  • Global
From
Global Human Milk Oligosaccharides Market Size, Share & Industry Trends Analysis Report By Application, By Type (2'FL, 3'FL, 3'SL, and 6'SL), By Concentration (Neutral, and Acidic), By Regional Outlook and Forecast, 2023 - 2030 - Product Image

Global Human Milk Oligosaccharides Market Size, Share & Industry Trends Analysis Report By Application, By Type (2'FL, 3'FL, 3'SL, and 6'SL), By Concentration (Neutral, and Acidic), By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • 266 Pages
  • Global
From
Human Milk Oligosaccharides In Infant Formula Market Size & Market Share Data, Latest Trend Analysis and Future Growth Intelligence Report - Forecast by Type, by Applications, Analysis and Outlook from 2023 to 2030 - Product Image

Human Milk Oligosaccharides In Infant Formula Market Size & Market Share Data, Latest Trend Analysis and Future Growth Intelligence Report - Forecast by Type, by Applications, Analysis and Outlook from 2023 to 2030

  • Report
  • 162 Pages
  • Global
From
Human Milk Oligosaccharides Market: Industry Size, Share, Competition, Trends, Growth Opportunities and Forecasts by Region - Insights and Outlook by Product, 2024 to 2031 - Product Image

Human Milk Oligosaccharides Market: Industry Size, Share, Competition, Trends, Growth Opportunities and Forecasts by Region - Insights and Outlook by Product, 2024 to 2031

  • Report
  • 156 Pages
  • Global
From
Human Milk Oligosaccharides (HMO) - Global Strategic Business Report - Product Image

Human Milk Oligosaccharides (HMO) - Global Strategic Business Report

  • Report
  • 99 Pages
  • Global
From

About the Human Milk Oligosaccharides Market

The Human Milk Oligosaccharides (HMOs) market is a segment of the Vitamins and Dietary Supplements industry. HMOs are a type of prebiotic found in human breast milk, and are believed to have a range of health benefits. They are used in a variety of products, including infant formula, dietary supplements, and functional foods. HMOs are gaining popularity due to their potential to improve gut health, boost immunity, and reduce the risk of certain diseases. They are also being studied for their potential to improve cognitive development in infants. The HMOs market is driven by increasing awareness of the health benefits of HMOs, as well as the growing demand for infant formula and dietary supplements. The market is expected to grow in the coming years, as more research is conducted on the potential health benefits of HMOs. Some companies in the Human Milk Oligosaccharides market include Abbott Nutrition, Nestle, Danone, FrieslandCampina, and Mead Johnson Nutrition. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.